Washington HB 2710: Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.

Status: By resolution, returned to House Rules Committee for third reading. (as of 2020-03-12)

State: Washington · Session: 2019-2020 · Bill: HB 2710

Subjects: PHARMACIES AND PHARMACISTS, HEALTH CARE AUTHORITY, DRUGS, INSURANCE

Sponsors: Robinson, Cody, Ormsby, Tarleton, Tharinger

View Washington HB 2710 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.